Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-κB activity in human macrophages in vitro

International Immunopharmacology

Volumn 12, Issue 4, 2012, Pages 643-650

  Li, Meihua ^a   Zhong, Xiaoning ^a   He, Zhiyi ^a   Wen, Mingzhi ^a   Li, Jiaquan ^a   Peng, Xinyan ^a   Liu, Guangnan ^a   Deng, Jingmin ^a   Zhang, Jianquan ^a   Bai, Jing ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke extract; Erythromycin; Histone deacetylases; Nuclear factor B; Proinflammatory cytokine

Indexed keywords

CIGARETTE SMOKE; ERYTHROMYCIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ASSAY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORIMETRY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ERYTHROMYCIN; HISTONE DEACETYLASES; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-8; MACROPHAGES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SMOKE; TOBACCO; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84862789695     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.12.022     Document Type: Article

References (54)

1. B.K. Rubin, and M.O. Henke Immunomodulatory activity and effectiveness of macrolides in chronic airway disease Chest 125 2004 70S 78S (Pubitemid 38200963)
2. E.J. Giamarellos-Bourboulis Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators Int J Antimicrob Agents 31 2008 12 20 (Pubitemid 350236720)
3. M.H. Gotfried Macrolides for the treatment of chronic sinusitis, asthma, and COPD Chest 125 2004 52S 60S [quiz S-1S]
4. D. Banerjee, D. Honeybourne, and O.A. Khair The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial Treat Respir Med 3 2004 59 65 (Pubitemid 38444332)
5. O. Culic, V. Erakovic, and M.J. Parnham Anti-inflammatory effects of macrolide antibiotics Eur J Pharmacol 429 2001 209 229 (Pubitemid 33043997)
6. Y.S. Lopez-Boado, and B.K. Rubin Macrolides as immunomodulatory medications for the therapy of chronic lung diseases Curr Opin Pharmacol 8 2008 286 291
7. P.J. Barnes Chronic obstructive pulmonary disease N Engl J Med 343 2000 269 280 (Pubitemid 30490396)
8. P. Rytila, T. Rehn, H. Ilumets, A. Rouhos, A. Sovijarvi, and M. Myllarniemi Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD Respir Res 7 2006 69
9. M. Saetta, G. Turato, P. Maestrelli, C.E. Mapp, and L.M. Fabbri Cellular and structural bases of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2001 1304 1309 (Pubitemid 32506590)
10. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, and L. Buzatu The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653 (Pubitemid 38787999)
11. P. Kirkham, and I. Rahman Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy Pharmacol Ther 111 2006 476 494 (Pubitemid 43832007)
12. P.J. Barnes Alveolar macrophages in chronic obstructive pulmonary disease (COPD) Cell Mol Biol (Noisy-le-grand) 50 2004 [Online Pub:OL627-37]
13. P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 2003 672 688 (Pubitemid 37258549)
14. V.M. Keatings, P.D. Collins, D.M. Scott, and P.J. Barnes Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma Am J Respir Crit Care Med 153 1996 530 534
15. B.G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I.M. Adcock, and P.J. Barnes Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages J Exp Med 200 2004 689 695 (Pubitemid 39258317)
16. F.D. Urnov, and A.P. Wolffe Chromatin remodeling and transcriptional activation: the cast (in order of appearance) Oncogene 20 2001 2991 3006 (Pubitemid 32553553)
17. K. Tomita, P.J. Barnes, and I.M. Adcock The effect of oxidative stress on histone acetylation and IL-8 release Biochem Biophys Res Commun 301 2003 572 577 (Pubitemid 36279279)
18. K. Ito, M. Ito, W.M. Elliott, B. Cosio, G. Caramori, and O.M. Kon Decreased histone deacetylase activity in chronic obstructive pulmonary disease N Engl J Med 352 2005 1967 1976 (Pubitemid 40638367)
19. P.J. Barnes Reduced histone deacetylase in COPD: clinical implications Chest 129 2006 151 155 (Pubitemid 43265256)
20. A.J. de Ruijter, A.H. van Gennip, H.N. Caron, S. Kemp, and A.B. van Kuilenburg Histone deacetylases (HDACs): characterization of the classical HDAC family Biochem J 370 2003 737 749 (Pubitemid 36399066)
21. K. Ito, P.J. Barnes, and I.M. Adcock Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12 Mol Cell Biol 20 2000 6891 6903
22. P.J. Barnes, K. Ito, and I.M. Adcock Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase Lancet 363 2004 731 733 (Pubitemid 38296564)
23. P.J. Barnes New concepts in chronic obstructive pulmonary disease Annu Rev Med 54 2003 113 129 (Pubitemid 37386387)
24. S.V. Culpitt, D.F. Rogers, P. Shah, C. De Matos, R.E. Russell, and L.E. Donnelly Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 2003 24 31 (Pubitemid 36015913)
25. I.M. Adcock, K. Ito, and P.J. Barnes Histone deacetylation: an important mechanism in inflammatory lung diseases COPD 2 2005 445 455 (Pubitemid 43879443)
26. P.J. Barnes, I.M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur Respir J 25 2005 552 563 (Pubitemid 40331188)
27. S.R. Yang, A.S. Chida, M.R. Bauter, N. Shafiq, K. Seweryniak, and S.B. Maggirwar Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages Am J Physiol Lung Cell Mol Physiol 291 2006 L46 L57
28. C. Sundstrom, and K. Nilsson Establishment and characterization of a human histiocytic lymphoma cell line (U-937) Int J Cancer 17 1976 565 577
29. K.C. Verhoeckx, S. Bijlsma, E.M. de Groene, R.F. Witkamp, J. van der Greef, and R.J. Rodenburg A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line Proteomics 4 2004 1014 1028 (Pubitemid 38450707)
30. C.A. Izeboud, R.M. Vermeulen, A. Zwart, H.P. Voss, A.S. van Miert, and R.F. Witkamp Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists Naunyn Schmiedebergs Arch Pharmacol 362 2000 184 189 (Pubitemid 30642530)
31. + channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin Cancer Chemother Pharmacol 56 2005 212 220 (Pubitemid 40884277)
32. H. Carp, and A. Janoff Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants Am Rev Respir Dis 118 1978 617 621 (Pubitemid 9027203)
33. C.A. Martey, S.J. Pollock, C.K. Turner, K.M. O'Reilly, C.J. Baglole, and R.P. Phipps Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer Am J Physiol Lung Cell Mol Physiol 287 2004 L981 L991
34. F.M. Moodie, J.A. Marwick, C.S. Anderson, P. Szulakowski, S.K. Biswas, and M.R. Bauter Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells FASEB J 18 2004 1897 1899 (Pubitemid 39602276)
35. O.H. Kramer, P. Zhu, H.P. Ostendorff, M. Golebiewski, J. Tiefenbach, and M.A. Peters The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 EMBO J 22 2003 3411 3420 (Pubitemid 36834871)
36. J.P. de Torres, A. Campo, C. Casanova, A. Aguirre-Jaime, and J. Zulueta Gender and chronic obstructive pulmonary disease in high-risk smokers Respiration 73 2006 306 310 (Pubitemid 43725787)
37. P.A. Crosbie, and M.A. Woodhead Long-term macrolide therapy in chronic inflammatory airway diseases Eur Respir J 33 2009 171 181
38. T. Suzuki, M. Yanai, M. Yamaya, T. Satoh-Nakagawa, K. Sekizawa, and S. Ishida Erythromycin and common cold in COPD Chest 120 2001 730 733 (Pubitemid 32885442)
39. T.A. Seemungal, T.M. Wilkinson, J.R. Hurst, W.R. Perera, R.J. Sapsford, and J.A. Wedzicha Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations Am J Respir Crit Care Med 178 2008 1139 1147
40. Z.Y. He, L.M. Ou, J.Q. Zhang, J. Bai, G.N. Liu, and M.H. Li Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease Respiration 80 2010 445 452
41. Y. Hoshino, T. Mio, S. Nagai, H. Miki, I. Ito, and T. Izumi Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line Am J Physiol Lung Cell Mol Physiol 281 2001 L509 L516
42. I. Rahman, and I.M. Adcock Oxidative stress and redox regulation of lung inflammation in COPD Eur Respir J 28 2006 219 242 (Pubitemid 44914279)
43. I. Rahman, P.S. Gilmour, L.A. Jimenez, S.K. Biswas, F. Antonicelli, and O.I. Aruoma Ergothioneine inhibits oxidative stress- and TNF-alpha-induced NF-kappa B activation and interleukin-8 release in alveolar epithelial cells Biochem Biophys Res Commun 302 2003 860 864 (Pubitemid 36294054)
44. M. Desaki, H. Okazaki, T. Sunazuka, S. Omura, K. Yamamoto, and H. Takizawa Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation Antimicrob Agents Chemother 48 2004 1581 1585 (Pubitemid 38544362)
45. L. Wu, J.H. Lin, K. Bao, P.F. Li, and W.G. Zhang In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-alpha stimulated Jurkat cells Int Immunopharmacol 9 2009 1105 1109
46. L. Wu, W. Zhang, L. Tian, K. Bao, P. Li, and J. Lin Immunomodulatory effects of erythromycin and its derivatives on human T-lymphocyte in vitro Immunopharmacol Immunotoxicol 29 2007 587 596 (Pubitemid 350261187)
47. I.M. Adcock, B. Cosio, L. Tsaprouni, P.J. Barnes, and K. Ito Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response Antioxid Redox Signal 7 2005 144 152 (Pubitemid 40187932)
48. I. Rahman, P.S. Gilmour, L.A. Jimenez, and W. MacNee Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation Mol Cell Biochem 234-235 2002 239 248 (Pubitemid 34777863)
49. S. Rajendrasozhan, H. Yao, and I. Rahman Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD COPD 6 2009 291 297
50. K. Ito, T. Hanazawa, K. Tomita, P.J. Barnes, and I.M. Adcock Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration Biochem Biophys Res Commun 315 2004 240 245 (Pubitemid 38175212)
51. K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, and P.J. Barnes Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 203 2006 7 13 (Pubitemid 43139638)
52. B.P. Ashburner, S.D. Westerheide, and A.S. Baldwin Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol Cell Biol 21 2001 7065 7077 (Pubitemid 32916079)
53. L. Chen, W. Fischle, E. Verdin, and W.C. Greene Duration of nuclear NF-kappaB action regulated by reversible acetylation Science 293 2001 1653 1657 (Pubitemid 32807844)
54. H. Zhong, M.J. May, E. Jimi, and S. Ghosh The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol Cell 9 2002 625 636 (Pubitemid 34273792)